Keyphrases
Radioactive Seed Localization
100%
Non-culprit Lesion
60%
Breast Reconstruction
59%
Non-palpable Breast Lesions
42%
Wire Localization
41%
Tape Stripping
38%
Ductal Carcinoma in Situ
38%
Metastatic Melanoma
38%
Invasive Breast Cancer
34%
Reoperation Rate
32%
Lymph Node
28%
Sentinel Lymph Node
23%
Breast Tissue
23%
Reoperation
22%
In Situ Breast Cancer
19%
Guidewire
19%
Renal Cell Carcinoma
19%
Radioguided Surgery
19%
I-125
19%
Von Hippel-Lindau Disease
19%
Labeled Seed
19%
Melanoma
19%
Lymph Node Ratio
19%
Lymphedema
19%
Occult Metastasis
19%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
19%
Prospective Observational Study
19%
Open-label Trial
19%
Diagnostic Study
19%
Mini
19%
Size-and-shape
19%
Patient-reported Outcomes
19%
Ribonucleic Acid
19%
Breast Lesions
19%
Preoperative Localization
15%
Rutile
15%
Ultrasound
15%
Pathologist
14%
Surgical Procedures
13%
Lesion Localization
13%
Positive Margins
12%
Breast Cancer Treatment
11%
Capital Region
11%
Mammography Screening
11%
Gamma Probe
10%
Radioactive Iodine
9%
Water Bath
9%
Quality of Life Satisfaction
9%
Secondary Lymphedema
9%
Sentinel Lymph Node Biopsy
9%
Medicine and Dentistry
Radioactive Seed
99%
Breast Cancer
53%
Reoperation
45%
Breast Lesion
44%
Quadrantectomy
41%
Intraductal Carcinoma
41%
Nodular Melanoma
38%
Lymph Node
29%
Iodine 125
24%
Breast Tissue
22%
Sentinel Node
22%
RNA Analysis
20%
Open-Label Trial
19%
Squamous Cell Carcinoma
19%
Oral Cavity
19%
Sentinel Lymph Node
19%
Clear Cell Renal Cell Carcinoma
19%
Lymphedema
19%
Observational Study
19%
Radiosurgery
19%
Patient-Reported Outcome
19%
Von Hippel-Lindau Disease
19%
Diagnosis
19%
Breast Reconstruction
19%
Metastatic Carcinoma
19%
Surgical Technique
18%
Gamma Probe
13%
Surgical Margin
13%
Mammography
13%
Pathologist
11%
Arm
9%
Secondary Lymphedema
9%
Radioactive Iodine
9%
Screening
9%
Breast Tumor
9%
Late Effect
9%
Quality of Life
9%
Biopsy
8%
Radiation Exposure
7%
Surgery
7%
Sensitivity and Specificity
7%
Mastectomy
6%
Surgeon
6%
Tissue Injury
6%
Nociception
6%
Intention-to-Treat Analysis
6%
RNA
6%
Mouth Squamous Cell Carcinoma
5%
Neck Dissection
5%
Clinical Trial
5%
